Demographic trends in mortality due to ovarian cancer in the United States, 1999-2020

doi:10.5306/wjco.v16.i6.108393

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 6

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (0)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-6) series, Tables (1-9) series.

Item

Count

PDF

HTML

Figures (1-6)

Tables (1-9)

Sum=0

Jun 24, 2025 (publication date) through Jun 20, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Clin Oncol. Jun 24, 2025; 16(6): 108393
Published online Jun 24, 2025. doi: 10.5306/wjco.v16.i6.108393

Demographic trends in mortality due to ovarian cancer in the United States, 1999-2020

Laiba Razaq, Arkadeep Dhali, Rick Maity, Abdul Rafae Faisal, Ali Shan Hafeez, Asad Zaman, Mohammad Abdullah Humayun, Muhammad Faizan, Mavra Shahid, Mamoona Majeed, Pramod Singh

Laiba Razaq, Mavra Shahid, Mamoona Majeed, Department of Internal Medicine, Akhtar Saeed Medical and Dental College, Lahore 54000, Pakistan

Arkadeep Dhali, Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Sheffield S5 7AU, United Kingdom

Rick Maity, Department of General Medicine, Institute of Post Graduate Medical Education and Research, Kolkata 700020, India

Abdul Rafae Faisal, Ali Shan Hafeez, Asad Zaman, Department of Internal Medicine, CMH Multan Institute of Medical Sciences, Multan 59070, Pakistan

Mohammad Abdullah Humayun, Department of Internal Medicine, Shalamar Institute of Health Sciences, Lahore 54840, Pakistan

Muhammad Faizan, Department of Internal Medicine, Hamad Medical Corporation, Doha 3050, Qatar

Pramod Singh, Department of Internal Medicine, Barhabise Primary Health Care Centre, Barhabise 45302, Nepal

Co-first authors: Laiba Razaq and Arkadeep Dhali.

Author contributions: Razaq L and Dhali A conceptualized the article and contributed equally as co-first authors. Razaq L, Dhali A, and Maity R conducted literature review; Faisal AR, Hafeez AS, Zaman A, Humayun MA, Faizan M, Shahid M, and Majeed M collected and curated data; Singh P supervised the work and wrote the revised manuscript; Razaq L, Dhali A, Maity R, Faisal AR, Hafeez AS, Zaman A, Humayun MA, Faizan M, Shahid M, and Majeed M wrote the primary manuscript. All authors have read and approved the final manuscript.

Institutional review board statement: This is a study from a publicly available dataset (https://wonder.cdc.gov/). Therefore, institutional review board approval is not applicable.

Informed consent statement: This is a study from a publicly available dataset (https://wonder.cdc.gov/). Therefore, informed consent is not applicable.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.

Data sharing statement: The raw data required to reproduce the above findings are available to download from https://wonder.cdc.gov/. The processed data required to reproduce the above findings are available to download from https://zenodo.org/records/14562503.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Arkadeep Dhali, Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital, Herries Road, Sheffield S5 7AU, United Kingdom. arkadipdhali@gmail.com

Received: April 14, 2025
Revised: April 25, 2025
Accepted: May 23, 2025
Published online: June 24, 2025
Processing time: 68 Days and 13.1 Hours

Core Tip

Core Tip: This epidemiological study analyzed ovarian cancer-related mortality trends in the United States from 1999 to 2020 using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database. Findings revealed a significant decline in age-adjusted mortality rates, dropping from 14.62 per 100000 in 1999 to 10.15 per 100000 in 2020. The greatest improvements occurred among non-Hispanic White women, in metropolitan areas, and within the Northeast and Midwest regions. Despite overall progress, geographic and demographic disparities persist, underscoring the need for targeted preventive strategies and equitable healthcare interventions to further decrease ovarian cancer mortality.